A mathematical model for fibro-proliferative wound healing disorders
The normal process of dermal wound healing fails in some cases, due to fibro-proliferative disorders such as keloid and hypertrophic scars. These types of abnormal healing may be regarded as pathologically excessive responses to wounding in terms of fibroblastic cell profiles and their inflammatory growth-factor mediators. Biologically, these conditions are poorly understood and current medical treatments are thus unreliable.
In this paper, the authors apply an existing deterministic mathematical model for fibroplasia and wound contraction in adult mammalian dermis (Olsenet al., J. theor. Biol.177, 113–128, 1995) to investigate key clinical problems concerning these healing disorders. A caricature model is proposed which retains the fundamental cellular and chemical components of the full model, in order to analyse the spatiotemporal dynamics of the initiation, progression, cessation and regression of fibro-contractive diseases in relation to normal healing. This model accounts for fibroblastic cell migration, proliferation and death and growth-factor diffusion, production by cells and tissue removal/decay.
Explicit results are obtained in terms of the model processes and parameters. The rate of cellular production of the chemical is shown to be critical to the development of a stable pathological state. Further, cessation and/or regression of the disease depend on appropriate spatiotemporally varying forms for this production rate, which can be understood in terms of the bistability of the normal dermal and pathological steady states—a central property of the model, which is evident from stability and bifurcation analyses.
The work predicts novel, biologically realistic and testable pathogenic and control mechanisms, the understanding of which will lead toward more effective strategies for clinical therapy of fibro-proliferative disorders.
Unable to display preview. Download preview PDF.
- Asmussen, P. D. and B. Söllner. 1993.Wound Care. Principles of Wound Healing. Hamburg: Beiersdorf Medical Bibliothek.Google Scholar
- Bowen-Pope, D. F., T. W. Malpass, D. M. Foster and R. Ross. 1984. Platelet-derived growth factorin vivo: levels, activity and rate of clearance.Blood 64, 458–469.Google Scholar
- Boykin, J. V. and J. A. Molnar. 1992. Burn scar and skin equivalents. InWound Healing: Biochemical and Clinical Aspects. I. K. Cohen, R. F. Diegelmann and W. J. Lindblad (Eds), pp. 523–540. Philadelphia: Saunders.Google Scholar
- Clark, R. A. F. 1988. Overview and general considerations of wound repair. InThe Molecular and Cellular Biology of Wound Repair. R. A. F. Clark and P. M. Henson (Eds), pp. 3–34. New York: Plenum.Google Scholar
- Clark, R. A. F. 1993. Regulation of fibroplasia in cutaneous wound repair.Am. J. Med. Sci. 306, 42–48.Google Scholar
- Ehrlich, H. P., A. Desmoulière, R. F. Diegelmann, I. K. Cohen, C. C. Compton, W. L. Garner, Y. Kapanci and G. Gabbiani. 1994. Morphological and immunochemical differences between keloid and hypertrophic scar.Am. J. Pathol. 145, 105–113.Google Scholar
- Flint, M. H. 1990. Connective tissue biology. InDupuytren's Disease: Biology and Treatment. R. M. McFarlane, D. A. McGrouther and M. H. Flint (Eds), p. 13–24. Edinburgh: Churchill Livingstone.Google Scholar
- Gabbiani, G. 1992. The biology of the myofibroblast.Kidney Int. 41, 530–532.Google Scholar
- Jennings, R. W. and T. K. Hunt. 1992. Overview of postnatal wound healing. InFetal Wound Healing, N. S. Adzick and M. T. Longaker (Eds), pp. 25–52. New York: Elsevier.Google Scholar
- Kirsner, R. S. and W. H. Eaglstein. 1993. The wound healing process.Dermatol. Clin. 11, 629–640.Google Scholar
- Mast, B. A. 1992. The skin. InWound Healing: Biochemical and Clinical Aspects. I. K. Cohen, R. F. Diegelmann and W. J. Lindblad (Eds), pp. 344–355. Philadelphia: Saunders.Google Scholar
- Murray, J. C. 1993. Scars and keloids.Dermatol. Clin. 11, 697–708.Google Scholar
- Murray, J. C. and S. R. Pinnell. 1992. Keloids and excessive dermal scarring. InWound Healing: Biochemical and Clinical Aspects. I. K. Cohen, R. F. Diegelmann and W. J. Lindblad (Eds), pp. 500–509, Philadelphia: Saunders.Google Scholar
- Murray, J. D. 1989.Mathematical Biology. New York: Springer-Verlag.Google Scholar
- Raines, E. W., D. F. Bowen-Pope and R. Ross. 1990. Platelet-derived growth factor. InHandbook of Experimental Pharmacology. M. B. Sporn and A. B. Roberts (Eds), Vol. 95, Part I, pp. 173–262. Heidelberg: Springer-Verlag.Google Scholar
- Rudolph, R., J. Vande Berg and H. P. Ehrlich. 1992. Wound contraction and scar contracture. InWound Healing: Biochemical and Clinical Aspects. I. K. Cohen, R. F. Diegelmann and W. J. Lindblad (Eds), pp. 96–114. Philadelphia: Saunders.Google Scholar
- Rudolph, R. and J. Vande Berg. 1991. The myofibroblast in Dupuytren's contracture.Hand Clin. 7, 683–692.Google Scholar
- Schürch, W., O. Skalli and G. Gabbiani. 1990. Cellular biology. InDupuytren's Disease: Biology and Treatment. R. M. McFarlane, D. A. McGrouther and M. H. Flint (Eds), pp. 31–47. Edinburgh: Churchill Livingstone.Google Scholar
- Skalli, O. and G. Gabbiani. 1988. The biology of the myofibroblast. Relationship to wound contraction and fibrocontractive diseases. InThe Molecular and Cellular Biology of Wound Repair. R. A. F. Clark and P. M. Henson (Eds), pp. 373–402. New York: Plenum.Google Scholar
- Skalli, O., W. Schürch, T. Seemayer, R. Lagacé, D. Montandon, B. Pittet and G. Gabbiani. 1989. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins.Lab. Invest. 60, 275–285.Google Scholar
- Sprugel, K. H., J. M. McPherson, A. W. Clowes and R. Ross. 1987. Effects of growth factorsin vivo.Am. J. Pathol. 129, 601–613.Google Scholar
- Traqui, P., D. E. Woodward, G. C. Cruywagen, J. Cook and J. D. Murray. 1996. A mechanical model for fibroblast-driven wound healing.J. Biol. Systems, in press.Google Scholar
- Vande Berg, J. S., R. Rudolph, W. L. Poolman and D. R. Disharoon. 1988. Comparative growth dynamics and actin concentration between cultured human myofibroblasts from granulating wounds and dermal fibroblasts from normal skin.Lab. Invest. 61, 532–538.Google Scholar